Consider This from NPR Folgen

It's easy to lose track of the seriousness of the legal cases involving Donald Trump, in part because there are just so many.This week the former president and current presidential candidate said he received a letter informing him he is a target in Special Counsel Jack Smith's investigation of the January 6, 2021 insurrection at the U.S. Capitol. Such a letter often precedes an indictment. And a grand jury in Fulton County, Georgia, may soon consider an election interference case there that could lead to yet another indictment of Trump.We hear about both cases in this episode.In participating regions, you'll also hear a local news segment to help you make sense of what's going on in your community.Email us at considerthis@npr.org.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

One of the most cutting-edge and controversial fields of biomedical research right now is the quest to create eggs and sperm in the lab for anyone with their own DNA. And now, private companies have jumped into the race to revolutionize the way humans reproduce.In vitro gametogenesis, or IVG, would enable infertile women and men to have children with their own DNA instead of genes from the sperm and eggs of donors. It would also provide queer couples the opportunity to have children biologically related to both partners. NPR health correspondent Rob Stein reports on the excitement and concerns this new technology has fueled.In participating regions, you'll also hear a local news segment to help you make sense of what's going on in your community.Email us at considerthis@npr.org.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Carlos Alcaraz's victory over Novak Djokovic in the Wimbledon final was the latest coronation of a tennis great from Spain.NPR's Rob Schmitz looks into how the country became such fertile ground for outstanding players.In participating regions, you'll also hear a local news segment to help you make sense of what's going on in your community.Email us at considerthis@npr.org.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy